Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Malignant Solid Tumor|Breast Cancer|Melanoma (Skin)
Interventions: DRUG: 68GaNOTA-Anti-MMR-VHH2
Sponsor: Universitair Ziekenhuis Brussel
Collaborators: Kom Op Tegen Kanker